Next Arc Research

Not logged in? You're viewing the Free tier. Join for free or log in to access your membership content.
Disclaimer: This content is for informational and educational purposes only and should not be construed as financial or investment advice. Always do your own research and consult a licensed financial advisor before making investment decisions.
Disclosure: The author holds a long position in BFLY.
← Back to Free Index

BFLY

Analysis as of: 2026-02-05
Butterfly Network, Inc.
Butterfly develops handheld ultrasound probes and cloud software used to capture, manage, and operationalize point-of-care medical imaging.
ai healthcare medical devices software
On Yahoo Finance ...
Jump to: Summary • Analysis • Opportunity • Risk • Trends • Third Party Analyst Consensus

Summary

From pocket imaging to trusted clinical workflow layer
The company can earn a higher-quality multiple if it converts handheld placements into enterprise workflow subscriptions and defensible study verification. The path is viable but gated by procurement timing and supply/inventory execution.

Analysis

Thesis
A small-cap, regulated hardware + workflow stack can compound non-linearly if it becomes the trusted “system of record” for point-of-care ultrasound studies (verification, auditability, outcomes-linked contracts), shifting value from device units to enterprise recurring revenue and durable retention.
Last Economy Alignment
Healthcare delivery shifts to time-saved, verification, and workflow reliability as cognition commoditizes; regulated capture + provenance + distribution into large health systems is a durable value surface.
Upgrade to Allocator to also access: Thesis Critique

Opportunity Outlook

Average Implied 5-Year Multiple
3.3x (from 5 most recent analyses)
Reasoning
The upside is a mix-shift from clinician-led device sales to repeatable enterprise deployments where workflow, compliance-grade evidence capture, and outcome-tied packaging become the buyer’s “job to be done.” If the company stabilizes device economics (fewer inventory surprises) and grows recurring software/services per deployed probe, investors can underwrite higher retention and a more software-like multiple vs a commodity handheld device vendor.
Upgrade to Allocator to also access: Simplified Opportunity Explanation

Risk Assessment

Overall Risk Summary
The main risk is a timing trap: enterprise adoption and software attach may scale slower than cash burn and supply/inventory volatility. If incumbents win procurement through bundling and the company cannot become a trusted workflow/evidence layer, it remains a lower-multiple device vendor and may need dilutive funding to keep investing.
Upgrade to Allocator to also access: Tech Maturity Risk Score, Adoption Timing Risk Score, Moat Strength Risk Score, Capital Needs Risk Score, Regulatory Risk Score, Execution Risk Score, Concentration Risk Score, Unit Economics Risk Score, Valuation Risk Score, Macro Sensitivity Risk Score

Third Party Analyst Consensus

12-Month Price Target
$5.19
Upgrade to Reader to also access: Bull Case, Base Case, Bear Case